Company: PFSA
Filing Date: 2025-10-09
Form Type: S-1
Source: 0001213900-25-097860
Chunk: 355

Company: Profusa, Inc.
Filing Date: 2025-10-09
Form: S-1
Chunk 355
---
ory note were as follows at December 31, 2024 and 2023:

|                            |     |   | December 31, 
         2024 |   |     |   | December 31, 
         2023 |   |
|:---------------------------|:----|:--|-------------:|:--|:----|:--|-------------:|:--|
| Input                      |     |   |              |   |     |   |              |   |
| Risk-free interest rate    |     |   |         4.18 | % |     |   |         5.48 | % |
| Expected term (years)      |     |   |         0.27 |   |     |   |         0.19 |   |
| Expected volatility        |     |   |   De minimis | % |     |   |   De minimis | % |
| Exercise price             |     | $ |        11.50 |   |     | $ |        11.50 |   |
| Fair value of Common stock |     | $ |        12.12 |   |     | $ |        11.16 |   |

The following table provides
a summary of the changes in the fair value of the Company’s Level 3 financial instruments that are measured at fair value on a recurring
basis for the years ended December 31, 2024 and 2023:

|                                             |     | Private   
 Placement 
 Warrants  |         |     | Representative’s 
 Warrants         |        |     | Warrant   
 Liability |         |
|:--------------------------------------------|:----|:----------|--------:|:----|:-----------------|-------:|:----|:----------|--------:|
| Fair value at December 31, 2023             |     | $         |  66,128 |     | $                |  5,123 |     | $         |  71,251 |
| Change in fair value of warrant liabilities |     |           | 227,772 |     |                  | 17,647 |     |           | 245,419 |
| Fair value at December 31, 2024             |     | $         | 293,900 |     | $                | 22,770 |     | $         | 316,670 |

|                                             |     | Private   
 Placement 
 Warrants  |          |   |